A detailed history of Pingora Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Pingora Partners LLC holds 190 shares of NVO stock, worth $16,600. This represents 0.02% of its overall portfolio holdings.

Number of Shares
190
Previous 190 -0.0%
Holding current value
$16,600
Previous $27.1 Million 16.58%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $19,400 - $25,824
190 New
190 $24.4 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pingora Partners LLC Portfolio

Follow Pingora Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pingora Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pingora Partners LLC with notifications on news.